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pediatric septic shock
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Extracorporeal blood purification techniques (EBTs)
are emerging as beneficial interventions in the
management of sepsis. Although the combination of
different EBTs has also been suggested as a poten-
tially effective approach in the early phases of sepsis
[1, 2], no data are available for pediatric septic
shock.
We reported a case of refractory septic shock in a
12-year-old girl, with a clinical history of acute
lymphatic leukemia and recent chemotherapy, who
was admitted to the emergency department (ED) be-
cause of fever and fatigue. In the ED ward, mean
arterial pressure (MAP) was below 50 mmHg and
did not improve after initial fluid resuscitation
(20 ml/kg). Empiric antimicrobial therapy was
initiated and the patient was admitted to the
pediatric intensive care unit. Because of severe per-
sistent hypotension with arterial lactate concentra-
tions of 74 mg/dl, epinephrine and norepinephrine
were initiated at 0.2 μg/kg/min and 0.08 μg/kg/min,
respectively. Six hours after admission, the patient
remained severely hypotensive (MAP of 45 mmHg)
despite fluid and vasopressor therapy and low-dose
hydrocortisone administration. In the absence of
oliguria, continuous renal replacement therapy
(CRRT) was started (continuous venovenous hemo-
diafiltration modality; effluent of 35–40 ml/kg.h)
with a high cutoff (HCO) filter (Septex®) in combin-
ation with a cartridge column (CC; Cytosorb®). A
significant reduction of vasopressor doses was ob-
served 48 hours after the initiation of EBT (Fig. 1).
A similar positive trend was observed for lactate (74
vs 32 mg/dl) and procalcitonin (65 vs 18 ng/ml)
concentrations. This “hybrid” EBT was continued
for 72 hours without adverse events. The patient
was successfully discharged after 10 days. The blood
cultures yielded Klebsiella pneumonia, related to a
percutaneously inserted central line infection.
In this case, the benefits of CRRT in the manage-
ment of fluid overload and metabolic abnormalities
in children with septic shock were associated with
the immune-modulatory effects of EBTs. HCO filters
are characterized by large pore size (e.g., cutoff
value of 70 kDa) with improved convective clear-
ance of middle molecular weight molecules, such as
cytokines [3]. CCs have a large surface area that
could also directly adsorb and clear inflammatory
mediators [4]. The combination of HCO-CRRT and
CC might have a synergistic effect in this setting
[5]; this association has not yet been explored in
the treatment of pediatric septic shock. Further
studies are needed to assess the feasibility as well as
the optimal timing of initiation of such an approach
in children suffering from septic shock.
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Fig. 1 Vasopressor and inotrope infusion rates during extracorporeal
blood purification (EBT)
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